Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Aliment Pharmacol Ther. 2019 Apr 1;49(9):1195–1204. doi: 10.1111/apt.15211

Table 3.

Rare functional variants identified in selected patients.

Subject Genetic ancestry Genetic dataset& Gene Variant (amino acid position) Variant (chromosomal position) gnomad MAF21± Polyphen Humdiv Prediction22
5 Eur Chip ABCB11 E297G 2–169847329-T-C 0.04% Probably damaging
7 Eur Chip ABCB11 I206V 2–169850388-T-C 0.00% Benign
11 Eur WGS ATP8B1 D70N 18–55373793-C-T 0.44% Probably damaging
13 Eur WGS ATP8B1 N45T 18–55398906-T-G 0.75% Possibly damaging
18 Eur WGS ABCB4 R590Q 7–87060844-C-T 0.68% Probably damaging
30 Eur WGS ATP8B1 D70N 18–55373793-C-T 0.44% Probably damaging
39 Eur Chip ABCB11 E297G 2–169847329-T-C 0.04% Probably damaging
41 AA WGS ABCB11 V1112I 2–169787252-C-T 0.02% Probably damaging

Eur indicates European, AA indicates African American;

&

Chip indicates Illumina HumanExome chip, WGS indicates whole-genome sequencing;

±

MAF is reported for non-Finnish Europeans for all cells except for the variant found in an African American patient, where the MAF reported is for Africans